Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study

Omalizumab is marketed for chronic severe asthma patients who are allergic to perennial allergens. Our purpose was to investigate whether omalizumab is also effective in persistent severe asthma due to seasonal allergens. Thirty patients with oral corticosteroid-dependent asthma were treated with Om...

Descripción completa

Detalles Bibliográficos
Autores principales: Domingo, Christian, Pomares, Xavier, Navarro, Albert, Rudi, Núria, Sogo, Ana, Dávila, Ignacio, Mirapeix, Rosa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372537/
https://www.ncbi.nlm.nih.gov/pubmed/28264494
http://dx.doi.org/10.3390/ijms18030521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372537/
https://www.ncbi.nlm.nih.gov/pubmed/28264494
http://dx.doi.org/10.3390/ijms18030521

Ejemplares similares